Our results indicate that PBMCs from patients with stable COPD or AECOPD had downregulated SCP2, which might point to severe metabolic disorder and thus that SCP2 downregulation might contribute to one of the common comorbidities of COPD [30]. This evidence concerns the gene SCP2 and metabolic disease.